What is needed from the EMA to be better prepared for future health threats?
Health Conversation
English - December 07, 2021 09:00 - 21 minutes - 48.5 MB - ★★★★★ - 1 ratingMedicine Health & Fitness Alternative Health health covid-19 r&d patients vaccines pharmaceutical pharma pharmaceutical industry research & development patient safety Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Welcome to 19 Conversations. Today we're asking Michel Stoffel, Senior Adviser Global Regulatory Affairs, GSK and Isabelle Bekeredjian-Ding, Head of Microbiology Division, Paul-Ehrlich-Institut "What is needed from the EMA to be better prepared for future health threats?". Listen to hear their discussion on the challenge and how we're preparing for the future.
Hosted on Acast. See acast.com/privacy for more information.